Docebo (DCBO) Cash & Equivalents (2021 - 2025)
Docebo's Cash & Equivalents history spans 5 years, with the latest figure at $74.0 million for Q4 2025.
- For Q4 2025, Cash & Equivalents fell 19.99% year-over-year to $74.0 million; the TTM value through Dec 2025 reached $74.0 million, down 19.99%, while the annual FY2025 figure was $74.0 million, 19.99% down from the prior year.
- Cash & Equivalents reached $74.0 million in Q4 2025 per DCBO's latest filing, down from $92.5 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $216.3 million in Q4 2022 to a low of $72.0 million in Q4 2023.
- Average Cash & Equivalents over 5 years is $134.0 million, with a median of $92.5 million recorded in 2024.
- Peak YoY movement for Cash & Equivalents: crashed 66.73% in 2023, then increased 28.62% in 2024.
- A 5-year view of Cash & Equivalents shows it stood at $215.3 million in 2021, then increased by 0.45% to $216.3 million in 2022, then crashed by 66.73% to $72.0 million in 2023, then rose by 28.62% to $92.5 million in 2024, then fell by 19.99% to $74.0 million in 2025.
- Per Business Quant, the three most recent readings for DCBO's Cash & Equivalents are $74.0 million (Q4 2025), $92.5 million (Q4 2024), and $72.0 million (Q4 2023).